An Open Label, Proof of Concept Study to Evaluate the Feasibility and Safety of Kidney Transplant From HCV Positive Donors Into HCV Negative Recipient
Latest Information Update: 18 Sep 2023
At a glance
- Drugs Sofosbuvir/velpatasvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Proof of concept; Therapeutic Use
- Acronyms USE-Hep C
- 29 Jul 2021 Status changed from recruiting to completed.
- 17 Jan 2019 New trial record